Vidasym Overview

  • Year Founded
  • 2009

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Grant

  • Latest Deal Amount
  • $1.48M

  • Investors
  • 3

Vidasym General Information

Description

Operator of a clinical-stage company intended to cure chronic kidney disease. The company is developing small molecule drugs primarily for renal disorders, providing patients to get relief from diseases.

Contact Information

Website
www.vidasym.com
Ownership Status
Privately Held (backing)
Financing Status
Angel-Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Primary Office
  • 2201 West Campbell Park Drive
  • Suite 13
  • Chicago, IL 60612
  • United States
+1 (847) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Vidasym Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Grant 01-Apr-2016 $1.48M 00.00 Completed Clinical Trials - General
5. Grant 11-May-2015 0000 00.00 Completed Clinical Trials - General
4. Grant 31-Aug-2014 00000 00.00 Completed Clinical Trials - General
3. Grant 31-Aug-2013 00000 00.00 Completed Startup
2. Angel (individual) $2.5M $2.5M Completed Startup
1. Angel (individual) Completed Startup
To view Vidasym’s complete valuation and funding history, request access »

Vidasym Patents

Vidasym Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2010236642-A1 Vitamin d receptor agonists and uses thereof Active 17-Apr-2009 0000000000
AU-2010236642-B2 Vitamin d receptor agonists and uses thereof Active 17-Apr-2009 0000000000
CA-2758698-A1 Vitamin d receptor agonists and uses thereof Active 17-Apr-2009 0000000000
CA-2758698-C Vitamin d receptor agonists and uses thereof Active 17-Apr-2009 0000000000
EP-2419403-A1 Vitamin d receptor agonists and uses thereof Active 17-Apr-2009 C07C401/00
To view Vidasym’s complete patent history, request access »

Vidasym Executive Team (3)

Name Title Board Seat Contact Info
Alan Lau Founder & Interim Chief Executive Officer
Ruth Wu-Wong Ph.D Chief Scientific Officer & President
You’re viewing 2 of 3 executive team members. Get the full list »

Vidasym Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
National Institutes of Health Government 000 0000 000000 0
U.S. Department of Health and Human Services Government 000 0000 000000 0
Alan Lau Angel (individual) Minority 000 0000 000000 0
To view Vidasym’s complete investors history, request access »